Confronting the Main Challenge in High Placebo Response Rates in Hidradenitis Suppurativa
When addressing the biggest hurdle in drug development for Hidradenitis Suppurativa (HS), the issue of high placebo response rates in clinical trials is unmistakably significant. The challenge lies in distinguishing between the mechanism of action (MOA) from placebo response at the endpoint. It is crucial to recognize that the primary concern often stems from the […]
How to Manage Placebo Response Rate in Atopic Dermatitis – Ensuring Reasonable Placebo – Response Rate â A Sponsorâs Guide
Welcome to the second installment of the series on placebo response rate in atopic dermatitis (AD). This series aims to explore the complexities and nuances of placebo response rates in AD clinical trials and dive into the analysis of high response rates. This article explores the concept of a reasonable placebo-response rate in atopic dermatitis […]
How to Manage Placebo Response Rate in Atopic Dermatitis (AD) – Placebo-Response Rates in AD
Welcome to the first article in the series on placebo response rate in atopic dermatitis. This series aim to explore strategies on how to ensure a reasonable response rate and dive into the analysis of high response rates in AD. This inaugural article will explore the various factors influencing placebo response rates, including the disease under study, mode […]
